Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 214 of 1,261
  1. US 11560561

    Modular polypeptide libraries and methods of making and using same

    The Regents of the University of California · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  2. US 11560363

    Synthesis of esuberaprost prodrugs

    United Therapeutics Corporation · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  3. US 11559585

    Conjugates of active pharmaceutical ingredients

    The Regents of the University of California · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  4. US 11560414

    Kits comprising myokines and platinum-based chemotherapeutic agents for treating colorectal cancer

    Northwestern University · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  5. US 11559565

    Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides

    United States Government as represented by the Department of Veterans Affairs · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  6. US 11560360

    Therapeutic compounds

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  7. US 11560372

    Heterocyclic compounds useful as modulators of acetylcholine receptors

    Takeda Pharmaceutical Company Limited · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  8. US 11560376

    Amino acid compounds and methods of use

    Pliant Therapeutics, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  9. US 11560354

    Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

    AXSOME MALTA LTD. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  10. US 11559588

    Materials and methods for treatment of Spinocerebellar Ataxia Type 1 (SCA1) and other Spinocerebellar Ataxia Type 1 Protein (ATXN1) gene related conditions or disorders

    CRISPR THERAPEUTICS AG · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  11. US 11560366

    Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  12. US 11560368

    Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  13. US 11559583

    Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for cancer

    Five Prime Therapeutics, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  14. US 11560356

    Compounds and compositions for the treatment of cancer

    The Regents of the University of California · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  15. US 11559576

    Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  16. US 11559609

    Bone-promoting thermoresponsive macromolecules

    Northwestern University · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  17. US 11560428

    CD33-binding polypeptides and uses thereof

    Inhibrx, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  18. US 11559567

    Dosage regimen for pegylated interferon

    PHARMAESSENTIA CORPORATION · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  19. US 11559533

    Compositions of bile acids and phenylbutyrate compounds

    Amylyx Pharmaceuticals, Inc. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  20. US 11559556

    Citrus fruit extract-mediated synthesis of tellurium nanomaterials having biomedical applications

    Northwestern University · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  21. US 11560559

    Inducing production of full-length progranulin (GRN) from nucleotides including mutations containing a premature stop codon (PTC)

    The United States as Represented by The Dept of Veteran Affairs (VA) · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  22. US 11560370

    5-membered heteroaryl carboxamide compounds for treatment of HBV

    ASSEMBLY BIOSCIENCES, INC. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  23. US 11559489

    Tuning of release kinetics in hydrogels

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted
  24. US 11559574

    Whole-cell cancer vaccines and methods for selection thereof

    BriaCell Therapeutics Corp. · Granted Jan 24, 2023 · Expires Jan 19, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.